CIMARa
Consortium for Intracranial Metastasis Academic Research
Consortium for Intracranial Metastasis Academic Research
This website will be undergoing significant updates in the coming months. The information currently included is very outdated. Check back soon for an updated website!
The CIMARa Consortium, formalized in June 2021, includes clinical investigators, research scientists, and patient advocates who share the collective goal of improving outcomes for patients with central nervous system (CNS) metastases through the awareness and coordination of multi-institutional clinical trials testing novel therapeutic agents for this unique patient population.
To establish an international infrastructure to enhance discovery and development of CNS metastasis therapies.
To provide a network of investigators who understand and are willing to advance and implement multi-center clinical trial opportunities for patients living with CNS metastases.
To develop opportunities that harmonize clinical trial end-points regarding CNS metastases outcomes.
To provide a common web-based forum for patients and providers to learn about clinical trial opportunities for CNS metastases.